Weisi Liu

Shanghai Key Laboratory Of Female Reproductive Endocrine Related Diseases
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Author Correction: EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.

Author Correction: EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.

Journal: Nature communications

Published: November 06, 2021

Study on Evaluation Model of Emergency Rescue Capability of Chemical Accidents Based on PCA-BP.

Study on Evaluation Model of Emergency Rescue Capability of Chemical Accidents Based on PCA-BP.

Journal: Computational intelligence and neuroscience

Published: May 21, 2020

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.

Journal: Oncotarget

Published: December 21, 2016

Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma.

Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma.

Journal: Urologic oncology

Published: September 26, 2016

Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.

Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.

Journal: The Journal of biological chemistry

Published: August 03, 2016

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.

Journal: Medicine

Published: November 13, 2015

Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.

Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.

Journal: Oncotarget

Published: October 26, 2015

Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 23, 2015

Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma.

Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma.

Journal: The Journal of biological chemistry

Published: April 11, 2015

EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.

EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.

Journal: Nature communications

Published: March 06, 2015

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

Journal: Cancer science

Published: December 13, 2014

Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.

Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.

Journal: Japanese journal of clinical oncology

Published: December 09, 2014

Showing 1-12 of 24

Last Updated: 09/26/2026